Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-01 Option Award | 2024-11-14 4:42 pm | N/A 2034-11-01 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer | 18,750 | $0 | 37,237 (Direct) | View |
| 2024-08-05 Tax Withholding | 2024-08-07 4:04 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer | 4,755 | $8.96 | 18,487 (Direct) | View |
| 2024-08-05 Option Award | 2024-08-07 4:04 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer | 16,200 | $0 | 18,487 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 5:02 pm | N/A 2034-02-13 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer | 40,500 | $0 | 46,430 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 4:46 pm | N/A 2033-02-13 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer | 20,900 | $0 | 20,900 (Direct) | View |
| 2023-02-03 Tax Withholding | 2023-02-07 4:10 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer | 2,119 | $44.16 | 5,260 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:10 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer | 6,750 | $0 | 5,260 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:02 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer | 9,500 | $0 | 9,500 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:43 pm | N/A 2032-02-11 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer | 11,400 | $0 | 11,400 (Direct) | View |
| 2021-10-01 Option Award | 2021-10-04 4:10 pm | N/A 2031-10-01 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer | 45,000 | $0 | 45,000 (Direct) | View |